Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 16 , ISSUE 2 ( April, 2012 ) > List of Articles

RESEARCH ARTICLE

Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: A Kashmir experience

Mohd Ashraf, Tanveer Iqbal Dar, Khursheed Alam Wani, Aijaz Malik, Sanjeed Ahmad, Tariq A Gojwari, Arshad Iqbal

Keywords : Heparin, prophylaxis, thrombosis

Citation Information : Ashraf M, Dar TI, Wani KA, Malik A, Ahmad S, Gojwari TA, Iqbal A. Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: A Kashmir experience. Indian J Crit Care Med 2012; 16 (2):71-74.

DOI: 10.4103/0972-5229.99107

License: CC BY-ND 3.0

Published Online: 01-04-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background and Objectives: Deep vein thrombosis (DVT) occurs at a lower rate in Asia than in the rest of the world. We wanted to study the significance and efficacy of low molecular weight heparin (LMWH) in prophylaxis of DVT in major general surgical patients in the Kashmir Valley (India, Asia) so as to make it a routine in our patients. Patients and Methods: This was a prospective study in which the effect of LMWH was compared with no prophylaxis. Results: LMWHs are more effective than no prophylaxis in the prevention of DVT and pulmonary thromboembolism in highest-risk general surgical patients (odds ratio = 16.64; 95% confidence interval = 3.63-1130.03; P-value = 0.014). Conclusion: LMWHs have a significant prophylactic effect on DVT in general surgical patients, with a higher benefit to risk ratio, and, in spite of the low incidence of DVT in Asia, its prophylaxis should routinely be considered in this part of the world as well, preferably in the form of LMWHs.


PDF Share
  1. Vascular diseases of the extremities. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison′s Principles of Internal Medicine. 15 th ed. New York City, U.S.: McGraw Hill Companies Inc; 2001. p. 1434-40.
  2. Deep vein thrombosis is not rare in Asia- The Singapore general hospital experience. Ann Acad Med Singapore 2002;31:761-4.
  3. Prophylaxis and treatment of DVT in general surgery. Am J Surg 2005;189:14-2.
  4. Prophylaxis of deep vein thrombosis in colorectal surgery. Dis Colon Rectum 1982;25:563-5.
  5. Postoperative thromboembolic complications despite heparin prophylaxis in major abdominal surgery. Ann Chir Gynaecol 1985;74:130-3.
  6. Venous disorders. In: Russell RC, Williams NS, Bulstrode CJK, editors. Bailey and Love′s Short Practice of Surgery 23 rd ed. U.K. Oxford University Press, Hodder Arnold; 2000. p. 251-3.
  7. Prevention of venous thrombosis after surgery: A review of enoxaparin. Br J Surg 1992;79:495-8.
  8. Risk of and prophylaxis of venous thromboembolism in hospital patients. BMJ 1992;305:567-4.
  9. Time of onset of thromboembolism. In: D Bergqvist, editor. Postoperative Thromboembolism. Berlin, Heidelberg: Springer-Verlag; 1983. p. 32-3.
  10. Anticoagulant, fibrinolytic and antiplatelet therapy. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison′s Principals of Internal Medicine. 15 th ed. New York City, U.S.: McGraw Hill Companies Inc; 2001. p. 758.
  11. Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
  12. Markers of haemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. Thromb Haemost 1993;70:909-14.
  13. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001;38 (Supp, 5):12-9.
  14. Randomized controlled trial of LMWH versus no DVT prophylaxis for major colon and rectal surgery in Asian patients. Dis Colon Rectum 1999;42:196-203.
  15. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery. Br J Surg 1997;84:1099-03.
  16. LMWH given the evening before surgery compared with conventional low dose heparin in prevention of thrombosis. Br J Surg 1988;75;888-91.
  17. Br J Surg. 2001; 88: 913-30
  18. A systematic review of deep venous thrombosis prophylaxis in cancer patients: Implications for improving quality. Ann Surg Oncol 2007;14:929-36.
  19. Efficacy and safety of a Low Molecular Weight Heparin and Standard Unfractionated heparin for prophylaxis of postoperative Venous Thromboembolism: Europian multicentric trial. World J Surg 1997;21:2-9.
  20. A comparative trial of Enoxaparin versus standard heparin for the prophylaxis of postoperative DVT in general surgery. Am J Surg 1995;169:567-71.
  21. Thromboembolic diseases in women. Ann Acad Med Singapore 1974;3:399-403.
  22. Prevention of venous thromboembolism. Chest 1995;108 (4Suppl):312-4.
  23. Enoxaparin in the prevention of DVT after major surgery: Multicentric study. The Italian study group. Int Surg 1993;78;271-5.
  24. Thrombosis research unit. Efficacy and safety of LMWH (cy216) in preventing postoperative venous thrombo embolism: A co-operative study. Br J Surg 1985;72:786-9.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.